Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Rosuvastatin, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Rosuvastatin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Rosuvastatin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Rosuvastatin Market Size Growth Rate by Type
    • 1.4.2 Purity 98.0%
    • 1.4.3 Purity 99.0%
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Rosuvastatin Market Size Growth Rate by Application
    • 1.5.2 Tablet
    • 1.5.3 Capsule
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Rosuvastatin Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Rosuvastatin Industry
      • 1.6.1.1 Rosuvastatin Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Rosuvastatin Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Rosuvastatin Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Rosuvastatin Market Size Estimates and Forecasts
    • 2.1.1 Global Rosuvastatin Revenue 2015-2026
    • 2.1.2 Global Rosuvastatin Sales 2015-2026
  • 2.2 Rosuvastatin Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Rosuvastatin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Rosuvastatin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Rosuvastatin Competitor Landscape by Players

  • 3.1 Rosuvastatin Sales by Manufacturers
    • 3.1.1 Rosuvastatin Sales by Manufacturers (2015-2020)
    • 3.1.2 Rosuvastatin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Rosuvastatin Revenue by Manufacturers
    • 3.2.1 Rosuvastatin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Rosuvastatin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Rosuvastatin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Rosuvastatin Revenue in 2019
    • 3.2.5 Global Rosuvastatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Rosuvastatin Price by Manufacturers
  • 3.4 Rosuvastatin Manufacturing Base Distribution, Product Types
    • 3.4.1 Rosuvastatin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Rosuvastatin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Rosuvastatin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Rosuvastatin Market Size by Type (2015-2020)
    • 4.1.1 Global Rosuvastatin Sales by Type (2015-2020)
    • 4.1.2 Global Rosuvastatin Revenue by Type (2015-2020)
    • 4.1.3 Rosuvastatin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Rosuvastatin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Rosuvastatin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Rosuvastatin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Rosuvastatin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Rosuvastatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Rosuvastatin Market Size by Application (2015-2020)
    • 5.1.1 Global Rosuvastatin Sales by Application (2015-2020)
    • 5.1.2 Global Rosuvastatin Revenue by Application (2015-2020)
    • 5.1.3 Rosuvastatin Price by Application (2015-2020)
  • 5.2 Rosuvastatin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Rosuvastatin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Rosuvastatin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Rosuvastatin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Rosuvastatin by Country
    • 6.1.1 North America Rosuvastatin Sales by Country
    • 6.1.2 North America Rosuvastatin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Rosuvastatin Market Facts & Figures by Type
  • 6.3 North America Rosuvastatin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Rosuvastatin by Country
    • 7.1.1 Europe Rosuvastatin Sales by Country
    • 7.1.2 Europe Rosuvastatin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Rosuvastatin Market Facts & Figures by Type
  • 7.3 Europe Rosuvastatin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Rosuvastatin by Region
    • 8.1.1 Asia Pacific Rosuvastatin Sales by Region
    • 8.1.2 Asia Pacific Rosuvastatin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Rosuvastatin Market Facts & Figures by Type
  • 8.3 Asia Pacific Rosuvastatin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Rosuvastatin by Country
    • 9.1.1 Latin America Rosuvastatin Sales by Country
    • 9.1.2 Latin America Rosuvastatin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Rosuvastatin Market Facts & Figures by Type
  • 9.3 Central & South America Rosuvastatin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Rosuvastatin by Country
    • 10.1.1 Middle East and Africa Rosuvastatin Sales by Country
    • 10.1.2 Middle East and Africa Rosuvastatin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Rosuvastatin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Rosuvastatin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Rosuvastatin Products Offered
    • 11.1.5 AstraZeneca Recent Development
  • 11.2 Teva Pharmaceutical Industries
    • 11.2.1 Teva Pharmaceutical Industries Corporation Information
    • 11.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
    • 11.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Teva Pharmaceutical Industries Rosuvastatin Products Offered
    • 11.2.5 Teva Pharmaceutical Industries Recent Development
  • 11.3 MSN Laboratories
    • 11.3.1 MSN Laboratories Corporation Information
    • 11.3.2 MSN Laboratories Description, Business Overview and Total Revenue
    • 11.3.3 MSN Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 MSN Laboratories Rosuvastatin Products Offered
    • 11.3.5 MSN Laboratories Recent Development
  • 11.4 Cadila Pharmaceuticals
    • 11.4.1 Cadila Pharmaceuticals Corporation Information
    • 11.4.2 Cadila Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.4.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Cadila Pharmaceuticals Rosuvastatin Products Offered
    • 11.4.5 Cadila Pharmaceuticals Recent Development
  • 11.5 LGM Pharma
    • 11.5.1 LGM Pharma Corporation Information
    • 11.5.2 LGM Pharma Description, Business Overview and Total Revenue
    • 11.5.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 LGM Pharma Rosuvastatin Products Offered
    • 11.5.5 LGM Pharma Recent Development
  • 11.6 Bal Pharma
    • 11.6.1 Bal Pharma Corporation Information
    • 11.6.2 Bal Pharma Description, Business Overview and Total Revenue
    • 11.6.3 Bal Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Bal Pharma Rosuvastatin Products Offered
    • 11.6.5 Bal Pharma Recent Development
  • 11.7 Changzhou Pharmaceutical Factory
    • 11.7.1 Changzhou Pharmaceutical Factory Corporation Information
    • 11.7.2 Changzhou Pharmaceutical Factory Description, Business Overview and Total Revenue
    • 11.7.3 Changzhou Pharmaceutical Factory Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Products Offered
    • 11.7.5 Changzhou Pharmaceutical Factory Recent Development
  • 11.8 Jingxin Pharm
    • 11.8.1 Jingxin Pharm Corporation Information
    • 11.8.2 Jingxin Pharm Description, Business Overview and Total Revenue
    • 11.8.3 Jingxin Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Jingxin Pharm Rosuvastatin Products Offered
    • 11.8.5 Jingxin Pharm Recent Development
  • 11.9 Zhejiang Hisun Pharmaceutical
    • 11.9.1 Zhejiang Hisun Pharmaceutical Corporation Information
    • 11.9.2 Zhejiang Hisun Pharmaceutical Description, Business Overview and Total Revenue
    • 11.9.3 Zhejiang Hisun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Products Offered
    • 11.9.5 Zhejiang Hisun Pharmaceutical Recent Development
  • 11.10 HEC Pharm
    • 11.10.1 HEC Pharm Corporation Information
    • 11.10.2 HEC Pharm Description, Business Overview and Total Revenue
    • 11.10.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 HEC Pharm Rosuvastatin Products Offered
    • 11.10.5 HEC Pharm Recent Development
  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Rosuvastatin Products Offered
    • 11.1.5 AstraZeneca Recent Development
  • 11.12 Nanjing Frochem Tech
    • 11.12.1 Nanjing Frochem Tech Corporation Information
    • 11.12.2 Nanjing Frochem Tech Description, Business Overview and Total Revenue
    • 11.12.3 Nanjing Frochem Tech Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Nanjing Frochem Tech Products Offered
    • 11.12.5 Nanjing Frochem Tech Recent Development
  • 11.13 Lianyungang Runzhong Pharmaceutical
    • 11.13.1 Lianyungang Runzhong Pharmaceutical Corporation Information
    • 11.13.2 Lianyungang Runzhong Pharmaceutical Description, Business Overview and Total Revenue
    • 11.13.3 Lianyungang Runzhong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Lianyungang Runzhong Pharmaceutical Products Offered
    • 11.13.5 Lianyungang Runzhong Pharmaceutical Recent Development
  • 11.14 Shandong Bechem Chemicals
    • 11.14.1 Shandong Bechem Chemicals Corporation Information
    • 11.14.2 Shandong Bechem Chemicals Description, Business Overview and Total Revenue
    • 11.14.3 Shandong Bechem Chemicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Shandong Bechem Chemicals Products Offered
    • 11.14.5 Shandong Bechem Chemicals Recent Development
  • 11.15 CTX Life Sciences
    • 11.15.1 CTX Life Sciences Corporation Information
    • 11.15.2 CTX Life Sciences Description, Business Overview and Total Revenue
    • 11.15.3 CTX Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 CTX Life Sciences Products Offered
    • 11.15.5 CTX Life Sciences Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Rosuvastatin Market Estimates and Projections by Region
    • 12.1.1 Global Rosuvastatin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Rosuvastatin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Rosuvastatin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Rosuvastatin Sales Forecast (2021-2026)
    • 12.2.2 North America: Rosuvastatin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Rosuvastatin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Rosuvastatin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Rosuvastatin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Rosuvastatin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Rosuvastatin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Rosuvastatin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Rosuvastatin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Rosuvastatin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Rosuvastatin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Rosuvastatin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Rosuvastatin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Rosuvastatin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Rosuvastatin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Rosuvastatin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Rosuvastatin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Rosuvastatin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Rosuvastatin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Rosuvastatin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Rosuvastatin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Rosuvastatin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rosuvastatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Rosuvastatin market is segmented into
    Purity 98.0%
    Purity 99.0%
    Other

    Segment by Application, the Rosuvastatin market is segmented into
    Tablet
    Capsule
    Others

    Regional and Country-level Analysis
    The Rosuvastatin market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Rosuvastatin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Rosuvastatin Market Share Analysis
    Rosuvastatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rosuvastatin business, the date to enter into the Rosuvastatin market, Rosuvastatin product introduction, recent developments, etc.
    The major vendors covered:
    AstraZeneca
    Teva Pharmaceutical Industries
    MSN Laboratories
    Cadila Pharmaceuticals
    LGM Pharma
    Bal Pharma
    Changzhou Pharmaceutical Factory
    Jingxin Pharm
    Zhejiang Hisun Pharmaceutical
    HEC Pharm
    Lunan Pharmaceutical
    Nanjing Frochem Tech
    Lianyungang Runzhong Pharmaceutical
    Shandong Bechem Chemicals
    CTX Life Sciences

    Buy now